Galena Biopharma to Present at the 7th Annual Bio-Europe International
LAKE OSWEGO, Ore., March 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma
(Nasdaq:GALE), a biotechnology company focused on developing innovative,
targeted oncology treatments addressing major unmet medical needs to advance
cancer care, today announced that Mark W. Schwartz, Ph.D., Executive Vice
President and Chief Executive Officer will present a corporate update at the
7^th Annual Bio-Europe International Partnering Conference. The presentation
will take place on Tuesday, March 12, 2013 at 9:15 AM local time at the Centre
Convencions Internacional Barcelona in Barcelona, Spain.
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company that develops innovative, targeted oncology
treatments that address major unmet medical needs to advance cancer care. For
more information please visit us at www.galenabiopharma.com.
The Galena Biopharma, Inc. logo is available at
CONTACT: Madeline Hatton
Toll free: +1 (855) 855-GALE (4253), ext. 109
IR Sense, LLC
+1 (503) 400-6995
Galena Biopharma, Inc.
Press spacebar to pause and continue. Press esc to stop.